KPNA5 Suppresses Malignant Progression of Ovarian Cancer Through Importing the PTPN4 Into the Nucleus
Open Access
- 27 March 2025
- journal article
- Published by Wiley in Cancer Medicine
- Vol. 14 (7) , e70731
Abstract
Background: Abnormal protein localization due to disrupted nucleoplasmic transport is common in tumor cells, but its mechanisms are not well understood. Nuclear pore complexes and nuclear transporter proteins are crucial for protein transport between the nucleus and cytoplasm. Evidence increasingly shows that abnormal expression of karyopherin family proteins disrupts protein translocation, affecting processes like cell differentiation, proliferation, apoptosis, and transcriptional regulation. However, their functions and roles in ovarian cancer remain unclear.Methods: The expression level of KPNA5 in ovarian cancer tissues and cells was detected by IHC, Western blot, and qPCR. CCK‐8 and colony formation assays were used to assess cell proliferation ability. Transwell assay was conducted to determine cell migration and invasion capacity. A xenograft model was used to assess the effect of KPNA5 on tumor growth in vivo.Results: KPNA5 expression is downregulated in ovarian cancer (OC) tissues. Low KPNA5 levels were associated with poor survival in OC patients, validated by an OC tissue sample cohort. Overexpression of KPNA5 significantly suppressed OC cell proliferation, tumor growth, and invasion in both in vitro and in vivo studies. Mechanistically, KPNA5 recognizes nuclear localization signals (NLSs) in PTPN4, mediating its nuclear transport and inhibiting STAT3 phosphorylation and its downstream signaling pathway. Similarly, PTPN4 overexpression reduced OC cell viability and invasion, also suppressing STAT3 phosphorylation.Conclusions: Our findings identify KPNA5 as a tumor suppressor in OC, presenting a potential therapeutic target for OC treatment.Keywords
This publication has 36 references indexed in Scilit:
- The nuclear pore complex: understanding its function through structural insightNature Reviews Molecular Cell Biology, 2016
- Importin α: a key molecule in nuclear transport and non-transport functionsThe Journal of Biochemistry, 2016
- Ebola Virus VP24 Targets a Unique NLS Binding Site on Karyopherin Alpha 5 to Selectively Compete with Nuclear Import of Phosphorylated STAT1Cell Host & Microbe, 2014
- PTPN4 negatively regulates CrkI in human cell linesCellular & Molecular Biology Letters, 2013
- Identification of Novel Therapeutic Targets in Microdissected Clear Cell Ovarian CancersPLOS ONE, 2011
- Decreased progesterone receptor isoform expression in luteal phase fallopian tube epithelium and high-grade serous carcinomaEndocrine-Related Cancer, 2011
- The protein tyrosine phosphatase PTPN4/PTP-MEG1, an enzyme capable of dephosphorylating the TCR ITAMs and regulating NF-κB, is dispensable for T cell development and/or T cell effector functionsMolecular Immunology, 2008
- Fibroblast Growth Factor 9 Has Oncogenic Activity and Is a Downstream Target of Wnt Signaling in Ovarian Endometrioid AdenocarcinomasCancer Research, 2006
- Importin α: a multipurpose nuclear-transport receptorTrends in Cell Biology, 2004
- Nuclear transport and cancer: from mechanism to interventionNature Reviews Cancer, 2004